Skip to main content

Month: November 2022

Total number of shares and voting rights in Zealand Pharma at November 30, 2022

Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.  In Company announcement No. 53/2022 from November 17, 2022, Zealand announced an increase in share capital relating to exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand...

Continue reading

Morien Resumes Quarterly Dividend Program

HALIFAX, Nova Scotia, Nov. 30, 2022 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company“) (TSX-V:MOX), is pleased to announce that as part of the Company’s strategy to maximize shareholder value, its board of directors (the “Board”) has approved the reinstatement of paying dividends. The Board has declared a special dividend of CAD $0.005 per common share payable on December 20, 2022, to shareholders of record as at the close of business on December 12, 2022. It is the Company’s current intention that in the first quarter of 2023 it will resume payment of quarterly dividends of $0.0025 per common share. Beyond 2023, as the Donkin Coal Mine scales up production, it is anticipated that quarterly dividends will be calculated in relation to cash flow available for distribution, having regard...

Continue reading

Vishay Intertechnology’s New Screw-Terminal Aluminum Capacitors Offer High Capacitance / Voltage Combinations in Smaller Case Sizes

Electrolytic Capacitors Offer High Ripple Currents Up to 49.6 A, Low ESR Down to 2 mΩ, and Long Useful Life to 10 000 h MALVERN, Pa., Nov. 30, 2022 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of screw-terminal aluminum electrolytic capacitors that allow designers to pack more energy storage into less space. Available in 11 case sizes ranging from 35 mm by 60 mm to 90 mm by 220 mm, the Vishay BCcomponents 202 PML-ST series offers high capacitance / voltage (CV) values in smaller case sizes than previous-generation solutions while providing increased ripple current to 49.6 A, lower ESR down to 2 mΩ, and a long useful life of 10 000 h at +85 °C. Featuring a cylindrical aluminum case insulated with a blue sleeve and pressure relief in their sealing disc, the electrolytic capacitors released...

Continue reading

CarGurus Study Finds Dogs Are More Relaxed in Electric Cars

Study conducted by U.K.-based University of Lincoln and CarGurus investigates the impact of electric vehicle travel on dog behavior and well-being CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — CarGurus (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today released a first-of-its-kind study examining the well-being of dogs in electric vehicles (EVs). Conducted in collaboration with the University of Lincoln in the United Kingdom, the study finds dogs are more relaxed in EVs than in diesel-powered cars. The CarGurus Dogs and EVs Study, which has been submitted for publication in an international scientific journal, was commissioned to investigate the effects of traveling in EVs on dog behavior and welfare. CarGurus and the University of Lincoln conducted the two-day...

Continue reading

Nine-month unaudited financial results of AB Pieno žvaigždės for 2022

According to preliminary unaudited data, the sales revenue of AB Pieno žvaigždės in the nine months of 2022 was EUR 157.2 million, or 18.3% more than a year earlier (nine-month sales revenue in 2021 was EUR 132.9 million).EBITDA for the nine months of 2022 was EUR 2.4 million, compared to EBITDA of EUR 7.1 million a year ago.In the nine months of 2022, the company incurred a loss of EUR 2.6 million. In the nine months of 2021, the company had a net profit of EUR 2.5 million. Audrius StatulevičiusCFO+370 52461419Attachment2022_q3_en_eur_solo_ias

Continue reading

Global Polymer Market to Hit Sales of $1 Trillion by 2028 | Smart Polymers are Making Their Way into Healthcare Sector

Global polymer market was valued at USD 701.79 Billion in 2021, and it is expected to reach a value of USD 1000.73 Billion by 2028, at a CAGR of 5.20% over the forecast period (2022–2028). Westford, USA, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global polymer market is expected to grow at CAGR of 5.2% during the forecast period. This growth is driven by the increasing demand for products made from polymers, such as plastics, composites, and elastomers. It is further supported by increasing demand for polymers in a variety of industries, such as automotive, construction, electronics and packaging. One of the drivers of this growth is the increasing deployment of 3D printing technology. Polymers can be used to create intricate and complex objects that wouldn’t be possible with other manufacturing methods. Over the next few years, SkyQuest...

Continue reading

Global Artificial Intelligence Market to Hit Sales of $895.71 Billion by 2028 | Healthcare to Contribute Over $194 Billion | SkyQuest Technology

Global artificial intelligence market is on the rise, and businesses are starting to take notice. SkyQuest has released its latest report on AI, which forecasts that the market will grow from $93.5 billion in 2021 to $895.71 billion by 2028 at a CAGR of 38.1% during the forecast period, 2022–2028. Westford, USA, Nov. 30, 2022 (GLOBE NEWSWIRE) — Growth of the global artificial intelligence market is likely to come from three main sources: increased demand from businesses for AI-powered automation, increased investment in AI research and development (R&D), and expansions of the use of AI across various industries. In particular, businesses are increasingly looking to use AI for tasks such as customer support, marketing, and sales. While all of this growth is good news for businesses, there are some risks associated with using...

Continue reading

Invesco ltd: Form 8.3 – Amgen Inc OPD

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Invesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Amgen Inc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing undertaken For...

Continue reading

Invesco ltd: Form 8.3 – Horizon Therapeutics plc OPD

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Invesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Horizon Therapeutics PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing...

Continue reading

Global Drone Simulator Market to Touch Valuation of $1450.39 Million By 2028 | Free Virtual Drone Simulator to Hinder Market Growth

Global drone simulator market size was valued at USD 612.70 Million in 2021, and it is expected to reach a value of USD 1450.39 Million by 2028, at a CAGR of 13.10% over the forecast period (2022–2028). Westford, USA, Nov. 30, 2022 (GLOBE NEWSWIRE) — There is a growing demand for drone simulator market that lets people practice flying without risking real-life injuries or financial damage. These simulators can be used to learn how to fly drones safely and efficiently, as well as to test new drone designs before they are released to the public. Some of the most popular drone simulators are available for free online, while others require a subscription fee. There are also commercially-produced simulators that can cost hundreds of dollars. The drone simulator market is growing at a rapid pace and is expected to reach $1,450 million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.